» Articles » PMID: 29282212

MUSCLEMOTION: A Versatile Open Software Tool to Quantify Cardiomyocyte and Cardiac Muscle Contraction In Vitro and In Vivo

Abstract

Rationale: There are several methods to measure cardiomyocyte and muscle contraction, but these require customized hardware, expensive apparatus, and advanced informatics or can only be used in single experimental models. Consequently, data and techniques have been difficult to reproduce across models and laboratories, analysis is time consuming, and only specialist researchers can quantify data.

Objective: Here, we describe and validate an automated, open-source software tool (MUSCLEMOTION) adaptable for use with standard laboratory and clinical imaging equipment that enables quantitative analysis of normal cardiac contraction, disease phenotypes, and pharmacological responses.

Methods And Results: MUSCLEMOTION allowed rapid and easy measurement of movement from high-speed movies in (1) 1-dimensional in vitro models, such as isolated adult and human pluripotent stem cell-derived cardiomyocytes; (2) 2-dimensional in vitro models, such as beating cardiomyocyte monolayers or small clusters of human pluripotent stem cell-derived cardiomyocytes; (3) 3-dimensional multicellular in vitro or in vivo contractile tissues, such as cardiac "organoids," engineered heart tissues, and zebrafish and human hearts. MUSCLEMOTION was effective under different recording conditions (bright-field microscopy with simultaneous patch-clamp recording, phase contrast microscopy, and traction force microscopy). Outcomes were virtually identical to the current gold standards for contraction measurement, such as optical flow, post deflection, edge-detection systems, or manual analyses. Finally, we used the algorithm to quantify contraction in in vitro and in vivo arrhythmia models and to measure pharmacological responses.

Conclusions: Using a single open-source method for processing video recordings, we obtained reliable pharmacological data and measures of cardiac disease phenotype in experimental cell, animal, and human models.

Citing Articles

An model for cardiac organoid production: The combined role of geometrical confinement and substrate stiffness.

Santoro R, Piacentini L, Vavassori C, Benzoni P, Colombo G, Banfi C Mater Today Bio. 2025; 31:101566.

PMID: 40061214 PMC: 11889630. DOI: 10.1016/j.mtbio.2025.101566.


Novel, low-cost bioreactor for electrical stimulation of cardiac cells.

Licata J, Gerstenhaber J, Lelkes P Front Bioeng Biotechnol. 2025; 13:1531731.

PMID: 39963172 PMC: 11830680. DOI: 10.3389/fbioe.2025.1531731.


Examination of mitochondria- and inflammasome-mediated mechanisms of clozapine-induced myocarditis using patient-derived iPSC cardiomyocytes.

Vaziri N, Shutt T, Karim W, Raedler T, Pantelis C, Thomas N Mol Psychiatry. 2025; .

PMID: 39962181 DOI: 10.1038/s41380-025-02935-z.


FORCETRACKER: A versatile tool for standardized assessment of tissue contractile properties in 3D Heart-on-Chip platforms.

Rivera-Arbelaez J, Dostanic M, Windt L, Stein J, Cofino-Fabres C, Boonen T PLoS One. 2025; 20(2):e0314985.

PMID: 39946364 PMC: 11825004. DOI: 10.1371/journal.pone.0314985.


Advances in cardiac organoid research: implications for cardiovascular disease treatment.

Huang Z, Jia K, Tan Y, Yu Y, Xiao W, Zhou X Cardiovasc Diabetol. 2025; 24(1):25.

PMID: 39827092 PMC: 11743075. DOI: 10.1186/s12933-025-02598-8.


References
1.
Zhang M, DAniello C, Verkerk A, Wrobel E, Frank S, Ward-van Oostwaard D . Recessive cardiac phenotypes in induced pluripotent stem cell models of Jervell and Lange-Nielsen syndrome: disease mechanisms and pharmacological rescue. Proc Natl Acad Sci U S A. 2014; 111(50):E5383-92. PMC: 4273331. DOI: 10.1073/pnas.1419553111. View

2.
van den Berg C, Elliott D, Braam S, Mummery C, Davis R . Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes Under Defined Conditions. Methods Mol Biol. 2015; 1353:163-80. DOI: 10.1007/7651_2014_178. View

3.
Hayakawa T, Kunihiro T, Ando T, Kobayashi S, Matsui E, Yada H . Image-based evaluation of contraction-relaxation kinetics of human-induced pluripotent stem cell-derived cardiomyocytes: Correlation and complementarity with extracellular electrophysiology. J Mol Cell Cardiol. 2014; 77:178-91. DOI: 10.1016/j.yjmcc.2014.09.010. View

4.
van Meer B, Tertoolen L, Mummery C . Concise Review: Measuring Physiological Responses of Human Pluripotent Stem Cell Derived Cardiomyocytes to Drugs and Disease. Stem Cells. 2016; 34(8):2008-15. PMC: 5113667. DOI: 10.1002/stem.2403. View

5.
Ran F, Hsu P, Wright J, Agarwala V, Scott D, Zhang F . Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 2013; 8(11):2281-2308. PMC: 3969860. DOI: 10.1038/nprot.2013.143. View